Intended for healthcare professionals


NICE recommends cannabis based drugs for epilepsy and multiple sclerosis

BMJ 2019; 367 doi: (Published 11 November 2019) Cite this as: BMJ 2019;367:l6453

Linked Opinion

New guidelines for prescribing medicinal cannabis—another dashed hope for patients

  1. Elisabeth Mahase
  1. The BMJ

In final appraisal documents the UK National Institute for Health and Care Excellence has recommended the use of cannabidiol with clobazam for treating seizures associated with two rare and severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.12

The decision comes after NICE initially rejected the use of cannabidiol in draft appraisal documents released in August because of concerns over a lack of data on the drug’s long term effectiveness.3

However, in its latest documents NICE has recommended the drug for people aged 2 or over, reporting …

View Full Text

Log in

Log in through your institution


* For online subscription